1. Home
  2. TWST vs ADNT Comparison

TWST vs ADNT Comparison

Compare TWST & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • ADNT
  • Stock Information
  • Founded
  • TWST 2013
  • ADNT 2016
  • Country
  • TWST United States
  • ADNT Ireland
  • Employees
  • TWST N/A
  • ADNT N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • ADNT Auto Parts:O.E.M.
  • Sector
  • TWST Health Care
  • ADNT Consumer Discretionary
  • Exchange
  • TWST Nasdaq
  • ADNT Nasdaq
  • Market Cap
  • TWST 2.3B
  • ADNT 2.0B
  • IPO Year
  • TWST 2018
  • ADNT N/A
  • Fundamental
  • Price
  • TWST $31.42
  • ADNT $24.11
  • Analyst Decision
  • TWST Buy
  • ADNT Hold
  • Analyst Count
  • TWST 9
  • ADNT 9
  • Target Price
  • TWST $48.56
  • ADNT $22.28
  • AVG Volume (30 Days)
  • TWST 1.8M
  • ADNT 1.0M
  • Earning Date
  • TWST 11-17-2025
  • ADNT 11-05-2025
  • Dividend Yield
  • TWST N/A
  • ADNT N/A
  • EPS Growth
  • TWST N/A
  • ADNT N/A
  • EPS
  • TWST N/A
  • ADNT N/A
  • Revenue
  • TWST $362,273,000.00
  • ADNT $14,409,000,000.00
  • Revenue This Year
  • TWST $22.11
  • ADNT $0.02
  • Revenue Next Year
  • TWST $17.50
  • ADNT N/A
  • P/E Ratio
  • TWST N/A
  • ADNT N/A
  • Revenue Growth
  • TWST 22.72
  • ADNT N/A
  • 52 Week Low
  • TWST $24.07
  • ADNT $10.04
  • 52 Week High
  • TWST $55.33
  • ADNT $26.16
  • Technical
  • Relative Strength Index (RSI)
  • TWST 69.28
  • ADNT 47.79
  • Support Level
  • TWST $26.20
  • ADNT $23.79
  • Resistance Level
  • TWST $33.12
  • ADNT $26.16
  • Average True Range (ATR)
  • TWST 1.49
  • ADNT 0.86
  • MACD
  • TWST 0.68
  • ADNT 0.00
  • Stochastic Oscillator
  • TWST 75.75
  • ADNT 25.56

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About ADNT Adient plc

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion and fiscal 2025 is guided to about $14.4 billion as foreign exchange helps offset some divested business.

Share on Social Networks: